| Source Date | Board Meeting Date | Details |
|
07-Aug-2024
|
16-Aug-2024
|
General Purpose.
|
|
29-Feb-2024
|
08-Mar-2024
|
General Purpose
|
|
19-Oct-2023
|
31-Oct-2023
|
Quarterly Results
|
|
17-Apr-2023
|
24-Apr-2023
|
Audited Results
|
|
01-Feb-2023
|
09-Feb-2023
|
Quarterly Results
|
|
06-Oct-2022
|
17-Oct-2022
|
Quarterly Results
|
|
03-Aug-2022
|
11-Aug-2022
|
Quarterly Results
|
|
18-May-2022
|
30-May-2022
|
Audited Results
|
|
31-Jan-2022
|
08-Feb-2022
|
Quarterly Results
|
|
22-Oct-2021
|
29-Oct-2021
|
Quarterly Results
|
|
23-Jul-2021
|
27-Jul-2021
|
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2021 ,inter alia, to consider and approve It is submitted that the intimation for date of Board Meeting was submitted at Exchange for 22.07.2021. However due to unavoidable circumstances it has been postponed to 27.07.2021.
|
|
15-Jul-2021
|
22-Jul-2021
|
Inter alia, to consider and approve the accounts of the Company for the period ended 31st March 2021.
|
|
03-Feb-2021
|
10-Feb-2021
|
Quarterly Results
|
|
22-Dec-2020
|
30-Dec-2020
|
Quarterly Results & A.G.M. Inter alia, to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 30th December 2020, to approve the Unaudited Quarterly Financial Results of the Company for the quarter ended 30th September 2020 and to approve the Annual Report 2019-20.
|
|
04-Sep-2020
|
11-Sep-2020
|
Quarterly Results
|
|
10-Jul-2020
|
20-Jul-2020
|
Audited Results
|
|
23-Jan-2020
|
31-Jan-2020
|
Quarterly Results
|
|
15-Oct-2019
|
29-Oct-2019
|
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2019 ,inter alia, to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 29th October 2019, to approve and take on record the Un-audited Quarterly Financial Results of the Company for the quarter and half year ended 30th September 2019.
|
|
25-Jul-2019
|
01-Aug-2019
|
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2019 ,inter alia, to consider and approve Madam/Sir, Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 1st August 2019, to approve and take on record the Un-audited Quarterly Financial Results of the Company for the quarter ended 30th June 2019. Requested to take the above on record please.
|
|
04-Apr-2019
|
11-Apr-2019
|
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/04/2019 ,inter alia, to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 11th April 2019, to approve and take on record the Un-audited Quarterly Financial Results of the Company for the quarter ended 31st March 2019.
|